Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3

Biochemical and Biophysical Research Communications

Volumn 349, Issue 2, 2006, Pages 674-682

  Ding, Zhi Chun ^a   Teng, Xin Chen ^a   Cai, Bin ^a   Wang, Hui ^c   Zheng, Qi ^a   Wang, Yang ^a   Zhou, Guo Ming ^a   Zhang, Ming Jie ^d   Wu, Hou Ming ^b   Sun, Hong Zhe ^c   Huang, Zhong Xian ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Cell culture assay; Human metallothionein 3; Mutants; Neuron growth inhibitory factor; NMR; S Nitrosylation

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); CYSTEINE DERIVATIVE; EDETIC ACID; GLUTAMIC ACID; GROWTH INHIBITOR; METAL; METALLOTHIONEIN III; MUTANT PROTEIN; NITRIC OXIDE SYNTHASE INHIBITOR; REAGENT; S NITROCYSTEINE; THIOL GROUP; UNCLASSIFIED DRUG; ZINC;

ACID BASE CATALYSIS; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BIOASSAY; CATALYSIS; CELL CULTURE; CIRCULAR DICHROISM; CONTROLLED STUDY; CULTURE MEDIUM; FETUS; GROWTH INHIBITION; HOMEOSTASIS; KINETICS; NERVE CELL GROWTH; NITROSYLATION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; RAT; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; TITRIMETRY; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; BRAIN; CELL PROLIFERATION; CELLS, CULTURED; GLUTAMIC ACID; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MUTATION; NERVE TISSUE PROTEINS; NEURONS; NITRIC OXIDE; RATS; ULTRAVIOLET RAYS;

EID: 33748417843     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.090     Document Type: Article

References (50)

1. Uchida Y., Takio K., Titani K., Ihara Y., and Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimers-disease brain is a 68-amino acid metallothionein-like protein. Neuron 7 (1991) 337-347
2. Hasler D.W., Faller P., and Vasak M. Metal-thiolate clusters in the C-terminal domain of human neuronal growth inhibitory factor (GIF). Biochemistry 37 (1998) 14966-14973
3. Faller P., and Vasak M. Distinct metal-thiolate clusters in the N-terminal domain of neuronal growth inhibitory factor. Biochemistry 36 (1997) 13341-13348
4. Palmiter R.D., Findley S.D., Whitemore T.E., and Durnam D.M. MT-III, a brain-specific of the metallothionein gene family. Proc. Natl. Acad. Sci. USA 89 (1992) 6333-6337
5. Tsuji S., Kobayashi H., Uchida Y., Ihara Y., and Miyatake T. Molecular-cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimers-Disease. EMBO J. 11 (1992) 4843-4850
6. Irie Y., and Keung W.M. Metallothionein-III antagonizes the neurotoxic and neurotrophic effects of amyloid beta peptides. Biochem. Biophys. Res. Commun. 282 (2001) 416-420
7. Irie Y., and Keung W.M. Anti-amyloid beta activity of metallothionein-III is different from its neuronal growth inhibitory activity: structure-activity studies. Brain Res. 960 (2003) 228-234
8. Uchida Y. Growth-inhibitory factor, metallothionein-like protein, and neurodegenerative diseases. Biol. Signals 3 (1994) 211-215
9. Arai Y., Uchida Y., and Takashima S. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome. Ped. Neurol. 17 (1997) 134-138
10. Sewell A.K., Jensen L.T., Erickson J.C., Palmiter R.D., and Winge D.R. Bioactivity of metallothionein-3 correlates with its novel beta-domain sequence rather than metal-binding properties. Biochemistry 34 (1995) 4740-4747
11. Romero-Isart N., Jensen L.T., Zerbe O., Winge D.R., and Vasak M. Engineering of metallothionein-3 neuron inhibitory activity into the inactive isoform metallothionein-1. J. Biol. Chem. 277 (2002) 37023-37028
12. Hasler D.W., Jensen L.T., Zerbe O., Winge D.R., and Vasak M. Effect of the two conserved prolines of human growth inhibitory factor (metallothionein-3) on its biological activity and structure fluctuation: comparison with a mutant protein. Biochemistry 39 (2000) 14567-14575
13. Cai B., Zheng Q., Teng X.C., Chen D., Wang Y., Wang K.Q., Zhou G.M., Xie Y., Zhang M.J., Sun H.Z., and Huang Z.X. The role of Thr5 in human neuron growth inhibitory factor. J. Biol. Inorg. Chem. 11 (2006) 476-482
14. 2+ release from metallothionein by destroying zinc-sulphur clusters without concomitant formation of S-nitrosothiol. Biochem. J. 344 (1999) 253-258
15. Chen Y., Irie Y., Keung W.M., and Maret W. S-nitrosothiols react preferentially with zinc thiolate clusters of metallothionein III through transnitrosation. Biochemistry 41 (2002) 8360-8367
16. Erickson J.C., Hollopeter G., Thomas S.A., Froelick G.J., and Palmiter R.D. Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J. Neurosci. 17 (1997) 1271-1281
17. Palmiter R.D. Constitute expression of metallothionein-3 (MT-3), but not MT-1, inhibits growth when cells become zinc-deficient. Toxicol. Appl. Pharmacol. 135 (1995) 139-146
18. Stamler J.S., Toone E.J., Lipton S.A., and Sucher N.J. NO signals: translocation, regulation, and a consensus motif. Neuron 18 (1997) 691-696
19. Hess D.T., Matsumoto A., Nudelman R., and Stamler J.S. S-nitrosylation: spectrum and specificity. Nat. Cell. Biol. 3 (2001) E46-E49
20. Kroncke K.D., and Kolb-Bachofen V. Measurement of nitric oxide-mediated effects on zinc homeostasis and zinc finger transcription factors. Methods Enzymol. 301 (1999) 126-135
21. Higucchi R., Krummel B., and Saiki R.K. A general method of in vitro preparation and specific mutagenesis of DNA fragments-study of protein and DNA interactions. Nucleic Acids Res. 16 (1988) 7351
22. Vasak M. Metal removal and substitution in vertebrate and invertebrate metallothioneins. Methods Enzymol. 205 (1991) 452-458
23. Winge D.R., and Miklossy K.A. Domain nature of metallothionein. J. Biol. Chem. 257 (1982) 3471
24. Li T.Y., Kraker A.J., Show III C.F., and Petering D.H. Ligand substitution-reactions of metallothioneins with EDTA and Apo-carbonic anhydrase. Proc. Natl. Acad. Sci. USA 77 (1980) 6334
25. Shaw III C.F., Savas M.M., and Petering D.H. Ligand substitution and sulfhydryl reactivity of metallothionein. Methods Enzymol. 205 (1991) 401-414
26. Pattanaik A., Bachowski G., Laib J., Lemkuil D., Shaw C.F., Petering D.H., Hitchcock A., and Saryan L. Properties of the reaction of Cis-dichlorodiammineplatinum(Ii) with metallothionein. J. Biol. Chem. 267 (1992) 16121-16128
27. Keefer L.K., Nims R.W., Davies K.M., and Wink D.A. Direct and indirect effects of nitric oxide in chemical reactions relevant to biology. Methods Enzymol. 268 (1996) 281-293
28. Piotto M., Saudek V., and Sklenar V. Gradient-tailored excitation for single-quantum NMR-spectroscopy of aqueous solutions. J. Biomol. NMR 2 (1992) 661-665
29. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPIPE-a multidimensional spectra processing system based on unix pipes. J. Biomol. NMR 6 (1995) 277-293
30. D. Goddard, G. Kneller, SPARKY 3, University of California, San Francisco.
31. Uchida Y., Ihara Y., and Tomonaga M. Alzheimer's disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats. Biochem. Biophys. Res. Commun. 150 (1988) 1263-1267
32. Erickson J.C., Sewell A.K., Jensen L.T., Winge D.R., and Palmiter R.D. Enhanced neurotrophic activity in Alzheimers-disease cortex is not associated with down-regulation of metallothionein-3 (GIF). Brain Res. 649 (1994) 297-304
33. Chung R.S., Vickers J.C., Chuah M.I., Eckhardt B.L., and West A.K. Metallothionein-3 inhibits initial neurite formation in developing neurons as well as postinjury, regenerative neurite sprouting. Exp. Neurol. 178 (2002) 1-12
34. Cismowski M.J., and Huang P.C. Effect of cysteine replacement at position 13 and position 50 on metallothionein structure. Biochemistry 30 (1991) 6626-6632
35. Chang C.C., Liao W.F., and Huang P.C. Cysteine contributions to metal binding preference for Zn/Cd in the beta-domain of metallothionein. Prot. Eng. 11 (1998) 41-46
36. Aravindakumar C.T., Ceulemans J., and De Ley M. Steric effect and effect of metal coordination on the reactivity of nitric oxide with cysteine-containing proteins under anaerobic conditions. Biophys. Chem. 85 (2000) 1-6
37. 7-MT2 using NMR spectroscopy. J. Mol. Biol. 225 (1992) 433-443
38. Balbach J., Forge V., Lau WS., vanNuland N.A.J., Brew K., and Dobson C.M. Protein folding monitored at individual residues during a two-dimensional NMR experiment. Science 274 (1996) 1161-1163
39. Schulman B.A., Kim P.S., Dobson C.M., and Redfield C. A residue-specific NMR view of the non-cooperative unfolding of a molten globule. Nat. Struct. Biol. 4 (1997) 630-634
40. Wang H., Zhang Q., Cai B., Li H.Y., Sze K.H., Huang Z.X., Wu H.M., and Sun H.Z. Solution structure and dynamics of human metallothionein-3 (MT-3). FEBS Lett. 580 (2006) 795-800
41. Masters B.A., Quaife C.J., Erickson J.C., Kelly E.J., Froelick G.J., Zambrowicz B.P., Brinster R.L., and Palmiter R.D. Metallothinein-3 is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci. 14 (1994) 5844-5857
42. Hidalgo J., Aschner M., Zatta P., and Vašák M. Roles of the metallothionein family of proteins in the central nervous system. Brain Res. Bull. 55 (2001) 133-145
43. Zangger K., Oz G., Haslinger E., Kunert O., and Armitage I.M. Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: potential role at inflammatory sites. FASEB J. 15 (2001) 1303-1305
44. Kroncke K.D., Fehsel K., Schmidt T., Zenke F.T., Dasting L., Wesener J.R., Bettermann H., Breunig K.D., and Kolb-Bachofen V. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem. Biophys. Res. Commun. 200 (1994) 1105-1110
45. 2+ and NO to form products with a g = 2.039 ESR signal. Biochem. Biophys. Res. Commun. 196 (1993) 632-635
46. Misra R.R., Hochadel J.F., Smith G.T., Cook J.C., Waalkes M.P., and Wink D.A. Evidence that nitric oxide enhances cadmium toxicity by displacing the metal from metallothionein. Chem. Res. Toxicol. 9 (1996) 326-332
47. Molinero A., Carrasco J., Hernandez J., and Hidalgo J. Effect of nitric oxide synthesis inhibition on mouse liver and brain metallothionein expression. Neurochem. Int. 33 (1998) 559-566
48. Schwarz M.A., Lazo J.S., Yalowich J.C., Allen W.P., Whitmore M., Bergonia H.A., Tzeng E., Billiar T.R., Robbins P.D., Lancaster Jr. J.R., and Pitt B.R. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc. Natl. Acad. Sci. USA 92 (1995) 4452-4456
49. Law A., Gauthier S., and Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res. Rev. 35 (2001) 73-96
50. 2+ ion. Biochemistry 34 (1995) 15091-15095